Review Types and Submission Deadlines

Do I need to submit for IRB review? 

Generally, IRB review is required for projects that is research involving human subjects. Click here to learn more. 

Exempt Reviews

To be exempt, the research must fall within specific criteria provided by federal regulations.

        NOTE: Exempt criteria is one area that will change with the Revised Common Rule. Click here to see a                comparison of exempt criteria.

Exempt research must be reviewed initially by the IRB but do not have to undergo continuing review by the IRB. 

        Who can determine exempt eligibility?

Qualified IRB staff or members review exempt applications. Investigators are NOT authorized to make an exempt determination.         

        What is considered when doing an exempt review?

The submission is reviewed to ensure exempt criteria are met and ensure compliance with ethical principles embodied in the Belmont Report (respect for persons, beneficence, and justice) are met. If HIPAA applies to the study, the IRB ensures compliance with HIPAA regulations as well.         

        What are the exempt review timelines?

Protocols are reviewed in the order in which they are received. Complete submissions should be submitted as soon as possible to ensure your research is not delayed. National average for approval is twelve (12) business days.

We strive to meet this timeline; however, incomplete submissions, protocols that are not well-developed, delays in receiving back changes requested from the study team, protocol volumes in the office and availability of members can impact this review time. 

Expedited Reviews

Protocols that fall within an expedited review category may be reviewed by one or more members of the IRB, however, the regulations allow the IRB to review at full board level.

What are the expedited review timelines?

Protocols are reviewed in the order in which they are received. Complete submissions should be submitted as soon as possible to ensure your research is not delayed, but not less than thirty (30) days in advance of your anticipated start date. National average for approval is twenty-one (21) business days.

We strive to meet this timeline; however, incomplete submissions, protocols that are not well-developed, delays in receiving back changes requested from the study team, protocol volumes in the office and availability of members can impact this review time.

Full Committee Reviews

Protocols not meeting exempt or expedited criteria are reviewed at a meeting attended by a majority of IRB members.

Full Committee Reviews generally occur on the first Friday of the month. The agenda and study materials must be provided to the IRB members in advance of the meeting with enough time to thoroughly review your study. The agenda closes the Wednesday of the week prior to the meeting to give members sufficient time to review the submission prior to the meeting.

Submissions must be received by the office prior to the agenda closing.

Submission Deadline

Agenda Closed

Full Board Meeting Date
3/21/2018 3/28/2018 4/6/2018
4/18/2018 4/25/2018 5/4/2018
5/23/2018 5/30/2018 6/8/2018
6/20/2018 6/27/2018 7/6/2018
7/18/2018 7/25/2018 8/3/2018
8/22/2018 8/29/2018 9/7/2018
9/19/2018 9/26/2018 10/5/2018
10/17/2018 10/24/2018 11/2/2018
11/21/2018 11/28/2018 12/7/2018

National average for approval is forty-one (41) business days for full board protocols.

For more information about IRB processes, see Regulations and Guidance on Human Subjects Research.